The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to ...

Sleep apnea, a condition that disrupts breathing during sleep, affects millions of people worldwide, especially adults over ...

Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...

This weight-loss drug, designed for obese patients, significantly reduces breathing disruptions and offers a new treatment ...

The FDA said studies have shown that by aiding weight loss, Zepbound helps reduce sleep apnea symptoms in some patients. In ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Zepbound was found to work on moderate to severe obstructive apnea in adults with obesity ... that the improvement in AHI and sleep apnea symptoms in those with OSA is related to weight reduction ...

“It’s important to understand OSA symptoms and know that treatments ... continue experiencing a benefit for sleep apnea.” At least 25 million adults in the U.S. have sleep apnea, according ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...